Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets
The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine. $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN